BSE filing, NSE: ASTAR. Summary written from the filing by ALFA Finder's alert engine.
Asian Star Company Ltd: key numbers
- Share price
- ₹616.40
- Market cap
- ₹986.7 Cr
- Revenue (annual)
- ₹2,882 Cr
- Net profit (annual)
- ₹40.42 Cr
- P/E (TTM)
- 30.4×Sector 49.0×
- Promoter holding
- 74.66%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Asian Star Company Ltd
All →Asian Star Company Board Meeting Date
Asian Star Company Ltd scheduled a board meeting on 4 November 2026 to consider half-year unaudited financial results. No decisions have been taken yet; the agenda is proposed only.
Asian Star Company Other Announcement
Asian Star Company Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI regulations.
Asian Star Company Credit Rating
Asian Star Company Limited received a reaffirmed credit rating (CARE A-; Stable/CARE A2+) with the outlook revised to 'Stable' by CARE Ratings.
Asian Star Company Annual General Meeting
Asian Star Company Ltd held its 32nd Annual General Meeting on September 28, 2026. The meeting covered financial adoption, dividend declaration, and re-appointment of directors.
Asian Star Company Price Movement Clarification
Asian Star Company Ltd told BSE the price movement is purely market-driven. The company confirmed Reg 30 LODR compliance and no withheld material information.
Asian Star Company Management Change
Asian Star announces Independent Director Bijayananda Pattanayak resigned effective September 8, 2026. He also ceases from the Nomination and Remuneration Committee citing other professional commitments.
Other board meeting date announcements
All →Bombay Oxygen Investments Board Meeting Date
Board meeting scheduled for Nov 6, 2026 to approve Q1 and H1 FY27 unaudited results. Trading window closed for insiders Oct 1–Nov 8, 2026.
OCCL Board Meeting Date
OCCL Ltd has scheduled its Board meeting for 6 November 2026 to consider Q1 FY27 unaudited results and a possible interim dividend. The trading window for designated persons closed from 1 October 2026.
TCM Board Meeting Date
TCM Limited intimated a Board meeting for 06/11/2026 to approve Q2 FY27 results. The trading window will reopen 48 hours after the results declaration.
Mercury Laboratories Board Meeting Date
Mercury Laboratories scheduled its Board meeting for November 5, 2026, to approve Q2/H1 FY27 results. Trading window remains closed until 48 hours post-announcement.
Salzer Electronics Board Meeting Date
Salzer Electronics Limited intimated a board meeting on 12 November 2026 to consider unaudited standalone and consolidated half-yearly results for September 2026. The trading window closes from 1 October to 14 November 2026.
Ekansh Concepts Board Meeting Date
Ekansh Concepts has scheduled a board meeting for November 5, 2026, to consider Q2 and H1 FY27 un-audited financial results. No figures are disclosed.